Clinical study on identifying key molecules of brain metastases from lung cancer and breast cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047907

Enrollment

Unknown

Registered

2021-06-27

Start date

2021-10-24

Completion date

Unknown

Last updated

2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glioma

Interventions

case series:None

Eligibility

Sex/Gender

All

Age

1 Years to 100 Years

Inclusion criteria

Inclusion criteria: Brain metastases and possible carcinoma in situ were surgically removed, and the images were read by more than 2 pathologists and diagnosed as brain metastases of lung cancer and breast cancer.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
He dye;immumohistochemical staining;	—

Countries

China

Contacts

Public ContactShi Yu

the First Affiliated Hospital of Army Medical University, PLA

drshiyu@126.com+86 13512350865

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026